| 4908 |
Centers for Disease Control and Prevention |
Html |
en |
Winnable Battles - Focus Areas |
CDC's Winnable Battles were chosen based on the scope of the health burden and our ability to make significant progress in improving outcomes. |
| measurable impact | 0.801221 |
| CDC Director | 0.57966 |
| death | 0.343065 |
| disability | 0.342991 |
| CDC leaders | 0.577869 |
| public health priorities | 0.710558 |
| effort | 0.350846 |
| burden | 0.356686 |
| public health challenges | 0.7414 |
| partnerships | 0.34776 |
| optimal strategies | 0.523404 |
| outcomes | 0.349398 |
|
| scope | 0.345318 |
| causes | 0.343139 |
| effective strategies | 0.514679 |
| term | 0.339336 |
| ability | 0.338773 |
| significant progress | 0.514528 |
| winnable battles | 0.987799 |
| charge | 0.346809 |
| priority areas | 0.522283 |
| pace | 0.360037 |
| resources | 0.33732 |
| large-scale impact | 0.526696 |
|
CLICK HERE |
| 7011 |
Centers for Disease Control and Prevention |
Html |
en |
Section 903 of the Federal Food, Drug, and Cosmetic Act -Misbranded Tobacco Products |
null |
| labeling conforms | 0.408684 |
| Health Education Act | 0.444027 |
| Tobacco Control Act | 0.640969 |
| section | 0.5023 |
| tobacco product subject | 0.565523 |
| specific tobacco products | 0.556682 |
| terms | 0.333786 |
| prior approval | 0.443475 |
| percentage | 0.332292 |
| case | 0.349542 |
| bear adequate directions | 0.459259 |
| packer | 0.353963 |
| opportunity | 0.326516 |
| respect | 0.330338 |
| sections | 0.325989 |
| tobacco products | 0.640765 |
| adequate warnings | 0.387205 |
| customary conditions | 0.390923 |
| risk tobacco products | 0.554086 |
| label bears | 0.386009 |
| relevant warnings | 0.380041 |
| Family Smoking Prevention | 0.559593 |
| subsection | 0.333629 |
| Secretary | 0.486187 |
| tobacco product manufacturer | 0.622547 |
|
| label containing | 0.399423 |
| numerical count | 0.387213 |
| Trade Commission Act | 0.445772 |
| advertisement | 0.328604 |
| Comprehensive Smokeless Tobacco | 0.553895 |
| public health | 0.379021 |
| tobacco product standard | 0.633044 |
| Advertising Act | 0.378515 |
| notice | 0.33093 |
| tobacco product | 0.966029 |
| Federal Cigarette Labeling | 0.460766 |
| small packages | 0.390432 |
| label statements | 0.426673 |
| accurate statement | 0.471104 |
| ordinary individual | 0.387256 |
| distributor | 0.346751 |
| sale | 0.331423 |
| regulation | 0.368891 |
| reasonable variations | 0.387538 |
| true statement | 0.382433 |
| regulations | 0.411516 |
| misbranding provisions | 0.387386 |
| descriptive printed matter | 0.44541 |
| information | 0.350875 |
|
CLICK HERE |
| 7182 |
Centers for Disease Control and Prevention |
Html |
null |
Influenza Risk Assessment Tool (IRAT) |
The Influenza Risk Assessment Tool (IRAT) helps assess the threat of influenza viruses with pandemic potential - CDC |
|
|
CLICK HERE |
| 7785 |
Centers for Disease Control and Prevention |
Html |
en |
CDCynergy Lite - Market Strategy - Health Communication |
Gateway to Health Communication and Social Marketing Practice - CDCynergy Lite, market strategy |
| tangible object | 0.467215 |
| smallest cost | 0.470559 |
| research findings | 0.472328 |
| competitive behaviors | 0.474868 |
| following information | 0.471612 |
| special promotional items | 0.5154 |
| Social marketing | 0.468453 |
| overall behavioral goal | 0.510471 |
| benefit exchange statement | 0.526509 |
| primary audience segments | 0.678586 |
| behavior change | 0.53038 |
| audience members | 0.640386 |
| condom vending machines | 0.517608 |
| target audience segment | 0.682709 |
| program resources | 0.473884 |
| tangible difference | 0.470502 |
| audience segment/behavior couplet | 0.640178 |
| cessation counseling | 0.464497 |
| commercial marketing | 0.468418 |
| potential segments | 0.482518 |
| female college students | 0.511314 |
| overall program goal | 0.528808 |
| male sex partners | 0.509889 |
| lower barriers | 0.5011 |
| largest number | 0.471341 |
|
| club program | 0.468078 |
| audience segment finalist | 0.678368 |
| benefits | 0.508186 |
| unproductive duplication | 0.465045 |
| target audience | 0.905204 |
| health behavior | 0.497143 |
| brainstorm interventions | 0.469043 |
| behavior | 0.676509 |
| little more incentive | 0.471855 |
| behavioral determinants | 0.53835 |
| pressure monitoring kits | 0.519638 |
| program activity | 0.471057 |
| greatest readiness | 0.474024 |
| priority segments | 0.472799 |
| target behavior | 0.522776 |
| information channels | 0.469478 |
| condensed format | 0.465788 |
| secondary audience segments | 0.653331 |
| audience segment | 0.875659 |
| solid exchange | 0.47453 |
| bar restrooms | 0.463745 |
| barriers | 0.571513 |
| public relations media | 0.515895 |
| primary target audience | 0.669547 |
|
CLICK HERE |
| 9346 |
Centers for Disease Control and Prevention |
Html |
es |
Intervenciones en el estilo de vida con relación a la hipertensión y la dislipidemia entre mujeres en edad reproductiva |
null |
| sólidas bases | 0.832117 |
| Dietz PM | 0.916352 |
| bajas tasas | 0.737923 |
| Tregear M | 0.877127 |
|
| Schmidt SM | 0.921712 |
| Chronic Dis | 0.920796 |
| Bombard J | 0.892276 |
| Tregear SJ | 0.877205 |
|
CLICK HERE |
| 11503 |
Centers for Disease Control and Prevention |
Html |
en |
Condom Fact Sheet In Brief | Condom Effectiveness |
Condom Effectivenss Fact Sheet in Brief |
| infected partner | 0.47256 |
| HIV prevention | 0.481633 |
| different STDs | 0.532346 |
| transmission | 0.518676 |
| numerous methodological challenges | 0.524213 |
| anal sex | 0.471456 |
| anatomic coverage | 0.472158 |
| sexual activity | 0.532802 |
| absolute protection | 0.479563 |
| genital fluids | 0.546326 |
| erect penis | 0.526129 |
| genital herpes | 0.562754 |
| infected area | 0.478805 |
| entire sex act | 0.599708 |
| sexually transmitted disease | 0.553493 |
| STD acquisition | 0.477667 |
| Laboratory studies | 0.471269 |
| various STDs | 0.530119 |
| human immunodeficiency virus | 0.535284 |
| consistent condom | 0.664337 |
| condom | 0.937007 |
| smallest STD pathogens | 0.544199 |
| new condom | 0.68348 |
| greater protection | 0.473016 |
|
| Condom Fact Sheet | 0.735527 |
| genital contact | 0.49612 |
| infected areas | 0.480178 |
| epidemiologic studies | 0.679476 |
| single sex act | 0.526878 |
| protection | 0.501166 |
| HIV-infected sex partners | 0.539243 |
| genital warts | 0.500386 |
| condom integrity | 0.611499 |
| Sex Transm Dis | 0.711602 |
| condom break | 0.616526 |
| reliable ways | 0.473617 |
| mutually monogamous relationship | 0.541239 |
| condom effectiveness | 0.686813 |
| genital human papillomavirus | 0.559799 |
| sexual transmission | 0.477505 |
| genital ulcer diseases | 0.556754 |
| condom users | 0.647784 |
| STD/HIV transmission | 0.478128 |
| risk | 0.48628 |
| infected persons | 0.490287 |
| male condoms | 0.611836 |
| HIV infection | 0.540605 |
| male latex condom | 0.74863 |
|
CLICK HERE |
| 12574 |
Centers for Disease Control and Prevention |
Video |
en |
February 2014 ACIP Meeting -- Human Papillomavirus (HPV) Vaccine |
Introduction, HPV type attribution in high grade cervical lesions in the United States, Population-Based HPV Genotype Attribution in HPV-Associated Cancers, United States, 9-valent HPV (9vHPV) Vaccine Program Key Results, and Summary and Future ACIP HPV Vaccine Workgroup Plans.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://streaming.cdc.gov/vod.php?id=336c94113b144920b256b8ae9cd4a1d220140410092058029 |
| ACIP Meeting | 0.933869 |
| Vaccine | 0.4669 |
|
| Human Papillomavirus | 0.839868 |
| YouTube | 0.478533 |
|
CLICK HERE |
| 13824 |
Centers for Disease Control and Prevention |
Image |
null |
Chronic Kidney Disease |
null |
|
|
CLICK HERE |
| 14290 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| malaria patients | 0.598247 |
| muscle pains | 0.498884 |
| public health authorities | 0.501014 |
| photo-induced electron transfer | 0.479915 |
| mosquito-borne parasitic infection | 0.497177 |
| acute febrile illnesses | 0.494114 |
| general malaise | 0.501997 |
| malaria infection | 0.585435 |
| hospital parasitology laboratory | 0.494636 |
| local malaria transmission | 0.645387 |
| health care providers | 0.573756 |
| smear microscopy | 0.488994 |
| effective patient care | 0.482893 |
| total patient samples | 0.485528 |
| school trip participants | 0.56533 |
| school group | 0.51927 |
| National Malaria Surveillance | 0.639397 |
| endemic malaria | 0.621382 |
| private health institutions | 0.496665 |
| falciparum malaria | 0.642945 |
| malaria parasites | 0.619952 |
| Puerto Rico school | 0.548895 |
| Public Health Laboratory | 0.502298 |
| Puerto Rico | 0.902438 |
| additional patient specimens | 0.484066 |
|
| 3Cook County Department | 0.482606 |
| original MMWR paper | 0.479906 |
| health alert notice | 0.499331 |
| malaria | 0.82742 |
| Punta Cana | 0.501289 |
| Puerto Rico Department | 0.618379 |
| 2Puerto Rico Department | 0.51235 |
| malaria symptoms | 0.586264 |
| fluorogenic real-time polymerase | 0.483872 |
| public health | 0.58323 |
| P. falciparum malaria | 0.632366 |
| dengue virus infection | 0.491569 |
| school trip participant | 0.493541 |
| Grupo HIMA San | 0.477529 |
| patient travel histories | 0.48038 |
| Public Health Preparedness | 0.499558 |
| malaria cases | 0.77148 |
| Health regional epidemiologists | 0.497626 |
| previous malaria cases | 0.64618 |
| school-organized graduation trip | 0.497729 |
| Dominican Republic | 0.680712 |
| Plasmodium falciparum malaria | 0.638006 |
| molecular diagnostic tests | 0.49345 |
| public health counterparts | 0.510199 |
|
CLICK HERE |
| 16307 |
Centers for Disease Control and Prevention |
Html |
en |
FastStats - Kidney Disease |
null |
| race | 0.221219 |
| United States | 0.80129 |
| potential life | 0.405868 |
| Final Data | 0.459678 |
| Hispanic origin Health | 0.972039 |
| sex | 0.221515 |
|
| age Health | 0.342896 |
| selected causes | 0.366568 |
| PDF | 0.327901 |
| MB | 0.45555 |
| Age-adjusted death rates | 0.643667 |
| deaths | 0.279189 |
|
CLICK HERE |